| Pharmaceutical Information |
| Drug Name |
Nafcillin sodium |
| Drug ID |
BADD_D01516 |
| Description |
A semi-synthetic antibiotic related to penicillin, Naficillin is a narrow-spectrum beta-lactam antibiotic drug. It is a beta-lactamase-resistant penicillin that is indicated for the treatment of Staphylococcal infections caused by strains that are resistant to other penicillins, except those caused by MRSA. It may be used as a first-line therapy in Methicillin-Sensitive *Staphylococcus aureus* infections [A20360]. |
| Indications and Usage |
Indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. |
| Marketing Status |
approved; investigational |
| ATC Code |
J01CF06 |
| DrugBank ID |
DB00607
|
| KEGG ID |
D00928
|
| MeSH ID |
D009254
|
| PubChem ID |
23667630
|
| TTD Drug ID |
D0A0JH
|
| NDC Product Code |
52946-0819; 25021-141; 55150-122; 70860-117; 63323-328; 66558-0202; 55150-124; 63323-327; 52946-0922; 25021-139; 25021-140; 55150-123; 70860-116; 61126-704; 70860-119 |
| UNII |
49G3001BCK
|
| Synonyms |
Nafcillin | Naphthamidopenicillin | Nafcil | Nafcillin Sodium | Sodium, Nafcillin | Nafcillin, Monosodium Salt, Anhydrous | Sodium Nafcillin | Nafcillin, Sodium |
|
| Chemical Information |
| Molecular Formula |
C21H21N2NaO5S |
| CAS Registry Number |
985-16-0 |
| SMILES |
CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
